Chardan Capital Initiates Coverage On Zura Bio With Buy Rating, Announces Price Target of $14
Chardan Capital Initiates Coverage On Zura Bio With Buy Rating, Announces Price Target of $14
Chardan Capital以買入評級開始對Zura Bio的報道,宣佈目標股價爲14美元
Chardan Capital analyst Matthew Barcus initiates coverage on Zura Bio (NASDAQ:ZURA) with a Buy rating and announces Price Target of $14.
Chardan Capital分析師馬修·巴庫斯以買入評級開始對祖拉生物(納斯達克股票代碼:ZURA)進行報道,並宣佈目標股價爲14美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。